1. Home
  2. PACB vs BRW Comparison

PACB vs BRW Comparison

Compare PACB & BRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • BRW
  • Stock Information
  • Founded
  • PACB 2000
  • BRW 1987
  • Country
  • PACB United States
  • BRW United States
  • Employees
  • PACB N/A
  • BRW N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • BRW Trusts Except Educational Religious and Charitable
  • Sector
  • PACB Industrials
  • BRW Finance
  • Exchange
  • PACB Nasdaq
  • BRW Nasdaq
  • Market Cap
  • PACB 364.2M
  • BRW N/A
  • IPO Year
  • PACB 2010
  • BRW N/A
  • Fundamental
  • Price
  • PACB $1.27
  • BRW $7.78
  • Analyst Decision
  • PACB Buy
  • BRW
  • Analyst Count
  • PACB 13
  • BRW 0
  • Target Price
  • PACB $2.46
  • BRW N/A
  • AVG Volume (30 Days)
  • PACB 8.5M
  • BRW 222.1K
  • Earning Date
  • PACB 05-08-2025
  • BRW 01-01-0001
  • Dividend Yield
  • PACB N/A
  • BRW 15.59%
  • EPS Growth
  • PACB N/A
  • BRW N/A
  • EPS
  • PACB N/A
  • BRW N/A
  • Revenue
  • PACB $154,014,000.00
  • BRW N/A
  • Revenue This Year
  • PACB $7.15
  • BRW N/A
  • Revenue Next Year
  • PACB $26.20
  • BRW N/A
  • P/E Ratio
  • PACB N/A
  • BRW N/A
  • Revenue Growth
  • PACB N/A
  • BRW N/A
  • 52 Week Low
  • PACB $1.08
  • BRW $7.15
  • 52 Week High
  • PACB $3.70
  • BRW $8.30
  • Technical
  • Relative Strength Index (RSI)
  • PACB 46.94
  • BRW 50.50
  • Support Level
  • PACB $1.08
  • BRW $7.72
  • Resistance Level
  • PACB $1.36
  • BRW $7.81
  • Average True Range (ATR)
  • PACB 0.09
  • BRW 0.08
  • MACD
  • PACB 0.01
  • BRW 0.01
  • Stochastic Oscillator
  • PACB 65.52
  • BRW 74.17

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Share on Social Networks: